SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
35 hedge funds and large institutions have $108M invested in Sinovac Biotech, Ltd in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 8 closing their positions.
Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
9
Reduced
13
Closed
8
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$41K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$15.6M |
| 2 |
2
Renaissance Technologies
New York
|
$9.62M |
| 3 |
GP
3
GLG Partners
London,
United Kingdom
|
$661K |
| 4 |
4
Two Sigma Investments
New York
|
$1.1M |
| 5 |
5
Millennium Management
New York
|
$320K |
